You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: December 23, 2024

Details for Patent: 7,381,427


✉ Email this page to a colleague

« Back to Dashboard


Summary for Patent: 7,381,427
Title:Seborrheic keratosis treatment
Abstract: The subject of the present invention is seborrheic keratosis removal and prevention utilizing safe dependable effective biocompatible treatments with no scarring, bleeding, burning, freezing, shocking, and hypopigmentation or hyperpigmentation.
Inventor(s): Ancira; Margaret (Phoenix, AZ), Miller; Mickey (Paradise Valley, AZ)
Assignee: Miller; Mickey (Paradise Valley, AZ)
Application Number:10/684,136
Patent Claim Types:
see list of patent claims
Use; Composition; Dosage form;
Patent landscape, scope, and claims:

United States Patent 7,381,427: A Detailed Analysis of Scope, Claims, and Patent Landscape

Introduction

United States Patent 7,381,427, titled "Seborrheic keratosis treatment," is a patent that provides topical compositions and methods for the treatment, removal, elimination, and prevention of seborrheic keratoses. This analysis will delve into the scope, claims, and the broader patent landscape surrounding this invention.

Background of Seborrheic Keratoses

Seborrheic keratoses are benign skin growths that are common in older adults. They can appear anywhere on the body but are most commonly found on the face, chest, shoulders, and back. While they are not harmful, they can be unsightly and sometimes itchy, leading to a desire for treatment.

Scope of the Patent

The patent US 7,381,427 focuses on topical treatments designed to address seborrheic keratoses. The scope includes:

  • Topical Compositions: The patent describes various topical compositions that can be used to treat seborrheic keratoses. These compositions may include ingredients such as hydrogen peroxide, glycolic acid, and various surfactants[1].
  • Methods of Treatment: The patent outlines methods for applying these compositions to effectively treat, remove, or prevent seborrheic keratoses.

Claims of the Patent

The claims of the patent are crucial as they define the legal boundaries of the invention. Here are some key aspects:

  • Composition Claims: The patent claims compositions that include at least one surfactant, such as sodium laurate, sodium lauryl sulfate, and lecithin, among others. These surfactants are combined with other active ingredients like hydrogen peroxide[1].
  • Method Claims: The patent claims methods for applying these compositions, including the frequency and duration of application, and the specific steps involved in the treatment process.

Key Ingredients and Their Roles

  • Hydrogen Peroxide: Known for its oxidizing properties, hydrogen peroxide is often used in dermatological treatments to help break down and remove unwanted skin lesions[5].
  • Surfactants: Surfactants like lecithin and sodium lauryl sulfate help in the formulation of the topical composition, enhancing its stability and effectiveness in penetrating the skin[1].

Patent Landscape: Related Patents and Technologies

The patent landscape for treatments of seborrheic keratoses includes a variety of other patents and technologies:

  • Dermatological Compositions: Other patents, such as US-4485091-A, also describe dermatological compositions that use hydrogen peroxide and other ingredients for skin treatments[5].
  • Treatment Methods: There are various methods patented for treating skin conditions, including laser treatments, cryotherapy, and chemical peels, which may complement or compete with the methods described in US 7,381,427.

Patent Eligibility and Legal Considerations

The eligibility of patents, especially those involving methods and compositions, is subject to strict scrutiny under U.S. patent law. Patents must meet the criteria set forth in 35 U.S.C. § 101, which excludes laws of nature, natural phenomena, and abstract ideas from patentability. The claims must also be inventive and not merely use conventional technology in an obvious way[2].

Impact on the Medical Field

The patent US 7,381,427 contributes to the medical field by providing a specific and effective treatment option for seborrheic keratoses. It offers dermatologists and patients a topical solution that can be less invasive than other treatments.

Market and Commercial Implications

The commercial success of a patent like US 7,381,427 depends on several factors, including market demand, competition from other treatments, and regulatory approvals. The patent's exclusivity period allows the patent holder to recoup investment in research and development.

Future Developments and Innovations

Future developments in the treatment of seborrheic keratoses may involve new ingredients, improved formulations, or innovative application methods. The patent landscape will continue to evolve as new patents are granted and existing ones expire.

Challenges and Limitations

One of the challenges faced by patents in the medical field is the need for rigorous clinical trials to prove efficacy and safety. Additionally, the patent must navigate the complex legal landscape to ensure that its claims are valid and enforceable.

Conclusion

United States Patent 7,381,427 is a significant contribution to the field of dermatology, offering a specific and effective treatment for seborrheic keratoses. Understanding the scope, claims, and broader patent landscape is crucial for both legal and commercial purposes.

Key Takeaways

  • Topical Compositions: The patent describes various topical compositions for treating seborrheic keratoses.
  • Method Claims: The patent outlines specific methods for applying these compositions.
  • Key Ingredients: Hydrogen peroxide and surfactants are key components.
  • Patent Landscape: The patent is part of a broader landscape that includes other dermatological treatments.
  • Legal Considerations: The patent must meet strict eligibility criteria under U.S. patent law.
  • Market Implications: The patent's commercial success depends on market demand and regulatory approvals.

Frequently Asked Questions (FAQs)

Q: What is the primary focus of United States Patent 7,381,427?

A: The primary focus is on topical compositions and methods for treating, removing, eliminating, and preventing seborrheic keratoses.

Q: What are some key ingredients in the topical compositions described in the patent?

A: Key ingredients include hydrogen peroxide and various surfactants such as lecithin and sodium lauryl sulfate.

Q: How does the patent navigate the legal landscape of patent eligibility?

A: The patent must meet the criteria set forth in 35 U.S.C. § 101, excluding laws of nature, natural phenomena, and abstract ideas, and must be inventive beyond conventional technology.

Q: What is the commercial significance of this patent?

A: The patent provides a specific treatment option for seborrheic keratoses, allowing the patent holder to recoup investment in research and development during its exclusivity period.

Q: How does this patent fit into the broader patent landscape for dermatological treatments?

A: It is part of a larger landscape that includes various other patents for treating skin conditions, offering a unique but complementary approach to existing treatments.

Cited Sources:

  1. US7381427B2 - Seborrheic keratosis treatment - Google Patents
  2. Electric Power Group, LLC v. Alstom S.A. - CAFC
  3. Patent Claims and Patent Scope - SSRN
  4. Search for patents - USPTO
  5. US-4485091-A - Dermatological Compositions | Unified Patents

More… ↓

⤷  Subscribe


Drugs Protected by US Patent 7,381,427

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Patented / Exclusive Use Submissiondate
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Patented / Exclusive Use >Submissiondate

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.